Table 1 Results from blood analyses performed over four years in an adolescent girl suffering an adverse event after ethosuximide treatment at age 12 years

Time from admission (months)

0

4

11

14

18

37

49

Peripheral blood count

normal

normal

normal

-

normal

normal

normal

E-SR

3

3

11

-

-

-

-

APTT (ref 30–42 sec)

50

-

45

-

45

-

43

Complement

Increased level of C3d and C3d/C3-fraction

Increased C3d/C3 fraction

Possible activation

normal

-

normal

-

-

ANA

Strong homogenous pattern^a

Strong homogenous pattern^a

normal

normal

normal

-

-

Anti-Scl-70 antibodies

Positive

Positive

Negative

Negative

Negative

-

-

Albumin (41–50) g/L

38

40

-

-

-

-

-